Calcium-vitamin D cosupplementation influences circulating inflammatory biomarkers and adipocytokines in vitamin D-insufficient diabetics: A randomized controlled clinical trial

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 12, 2014, Pages E2485-E2493

  Tabesh, Maryam ^a   Azadbakht, Leila ^a,b   Faghihimani, Elham ^c   Tabesh, Marjan ^a,b   Esmaillzadeh, Ahmad ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CALCIUM CARBONATE; COLECALCIFEROL; INTERLEUKIN 6; LEPTIN; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CALCIUM INTAKE; VITAMIN; VITAMIN D;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; AGED; BLOOD; CALCIUM INTAKE; DIABETES MELLITUS, TYPE 2; DIET SUPPLEMENTATION; METABOLISM; MIDDLE AGED; THERAPEUTIC USE;

ADIPOKINES; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCIUM, DIETARY; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84916641349     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1977     Document Type: Article

References (33)

1. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA. 2003;289:76-79.
2. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. Diabetes Care. 2004;27:1047-1053.
3. Esteghamati A, Gouya MM, Abbasi M, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran. Diabetes Care. 2008;31:96-98.
4. Hu FB, Meigs JB, Li TY, et al. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004;53:693-700.
5. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-334.
6. King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79:1527-1534.
7. Pittas AG, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006;29:650-656.
8. Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM. 2002;95:787-796.
9. Chagas CEA, Borges MC, Martini LA, et al. Focus on Vitamin D, inflammation and type 2 diabetes. Nutrients. 2012;4:52-67.
10. Palomer X, González-Clemente JM, Blanco-Vaca F, et al. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10:185-197.
11. Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus. Endocrine. 2009;35:11-17.
12. Panagiotakos DB, Pitsavos CH, Zampelas AD, et al. Dairy products consumption is associated with decreased levels of inflammatory markers related to cardiovascular disease in apparently healthy adults: the ATTICA study. J Am Coll Nutr. 2010;29:357-364.
13. Esmaillzadeh A, Azadbakht L. Dairy consumption and circulating levels of inflammatory markers among Iranian women. Public Health Nutr. 2010;13:1395-1402.
14. da Silva Ferreira T, Torres MR, Sanjuliani AF. Dietary calcium intake is associated with adiposity, metabolic profile, inflammatory state and blood pressure, but not with erythrocyte intracellular calcium and endothelial function in healthy pre-menopausal women. Br J Nutr. 2013;110:1079-1088.
15. Shab-Bidar S, Neyestani TR, Djazayery A, et al. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab Res Rev. 2012;28:424-430.
16. Grossmann RE, Zughaier SM, Liu S, et al. Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutr. 2012;66:1072-1074.
17. Wamberg L, Kampmann U, Stødkilde-Jørgensen H, et al. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial. Eur J Intern Med. 2013;24:644-649.
18. Wood AD, Secombes KR, Thies F, et al. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab. 2012;97:3557-3568.
19. Noda M, Mizoue T. Relation between dietary calcium and vitamin D and risk of diabetes and cancer: a review and perspective. J Clin Metab Diabetes. 2010;1:55-60.
20. Hopkins MH, Owen J, Ahearn T, et al. Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial. Cancer Prev Res (Phila). 2011;4:1645-1654.
21. Pittas AG, Harris SS, Stark PC, et al. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30:980-986.
22. Gannage-Yared MH, Azoury M, Mansour I, et al. Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J Endocrinol Invest. 2006;26:748-753.
23. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32:498-504.
24. Spranger J, Kroke A, Möhlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the Prospective Population-Based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. 2003;52:812-817.
25. Inomata S, Kadowaki S, Yamatani T, et al. Effect of 1α25 (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner. 1986;1:187-192.
26. Sanchez M, de la Sierra A, Coca A, et al. Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. Hypertension. 1997;29:531-536.
27. Major GC, Alarie F, Dore J, et al. Supplementation with calcium, vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr. 2007;85:54-59.
28. Neyestani TR, Nikooyeh B, Alavi-Majd H, et al. Improvement of vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes. J Clin Endocrinol Metab. 2012;97:2005-2011.
29. Beilfuss J, Berg V, Sneve M, et al. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-α and insulin resistance in overweight and obese subjects. Cytokine. 2012;60:870-874.
30. Sokol SI, Srinivas V, Crandall JP, et al. The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med. 2012;17:394-404.
31. Seshadria KG, Tamilselvana B, Rajendrana A. Role of vitamin D in diabetes. J Endocrinol Metab. 2011;1:47-56.
32. Sun X, Zemel MB. Calcitriol and calcium regulate cytokine production and adipocyte - macrophage cross-talk. J Nutr Biochem. 2008;19:392-399.
33. Grey A, Mitnick MA, Shapses S, Ellison A, Gundberg C, Insogna K. Circulating levels of interleukin-6 and tumor necrosis factor-α are elevated in primary hyperparathyroidism and correlate with markers of bone resorption - a clinical research center study. J Clin Endocrinol Metab. 1996;81:3450-3454.